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Introduction
All cells if the immune system arise from multipotent
stem cells which undergo differentiation, maturation
and migration from primary lymphoid organs into sec-
ondary lymphoid organs [1,2].
CD4+ and CD8+ T cells subpopulations play
important biological functions [3]. CD4+ cells are
called helper T cells [4]. They generate or stimulate
production of specific cytokines, and then they influ-
ence on inflammatory process [5,6]. CD8+ T cells are
called cytotoxic T cells [7]. They have the ability for
activation, suppression and cytotoxicity [8]. Heteroge-
nous population of these cells is studied to character-
ize CD4+ memory T cells and CD8+ memory T cells
with their subsets: central memory cells, effector
memory cells and naive memory cells [9].
Memory T cells population have ability to survive
in host after the completion of the immune response
and they provide long-term protection against reinfec-
tion [10]. Speed and effectiveness of the secondary
response upon reinfection depends on qualitative and
quantitative differences of memory T cells in compar-
ison with naive cells [11,12]. Precise mechanisms of
memory T cells development steal are not well under-
stood [13,14]. There are four potential mechanisms
which may lead to the generation of memory cells
[15]. The first model establishes the presence of sepa-
rate naive precursors of effectors and memory T cells,
in contrast to the second model which establishes that
T cells constitute uniform population of precursors
[16]. According to the third one, memory cells are
derived directly from effector cells [17]. The influence
of a level and time of stimulus duration for the gener-
ation of memory T cells considered in the fourth model
of memory T cells formation [18].
Memory T cells are heterogenous in terms of their
phenotype, anatomical distribution and functional
properties [19]. The difference in occurrence of the CC
chemokine receptor 7 (CCR7) and L-selectin (CD62-
L) on the memory T cells surface is characteristic fea-
ture of these cells used to subdivide them into two
functionally distinct T cells subsets [20,21]. Memory T
cells may be defined as central memory T cells (CM)
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and effector memory T cells (EM). CM cells exhibits
presence of the CCR7 and high expression of CD62L
[22]. However on the EM cells lack is CCR7 and the
expression level of CD62L is low [23]. Besides, iden-
tification of the memory T cells based on the expres-
sion of CD45RA on their surfaces, allows to differen-
tiation of TEMRA among CD8+ T cells [24]. Other
memory T cells subsets do not exhibit CD45RA
expression on their surface. In the line with distinct
expression of markers on memory T cells surface, they
exhibit different localization [25]. CM cells mainly are
present in secondary lymphoid organs and EM T cells
in peripheral nonlymphoid tissues [26]. Differences in
the phenotype of memory CD4+ and CD8+ T cells
influence on different functions which these cells play
in immune response. EM T cells provide a first line of
defense against antigen. These cells are able to
extravasate into peripheral tissues and they have a high
potential of immediate effector functions. CM T cells
are responsible for maintaining long-term protection
upon reinfection. They have a high proliferative capac-
ity and little potential of immediate cytotoxic function
[27,28].
The pathophysiology of chronic venous disease
(CVD) is not well understood, but it is known that
always inflammatory changes are present. Moreover,
the inflammatory process is investigated as the major
cause of CVD [29].
Chronic venous disease (CVD) is a very common
disease, which is significant social, medical and eco-
nomic problem. The reason of the majority of CVD
symptoms, (teleangiectases, varicose veins, edema,
trophic changes, chronic leg ulceration), is prolonged
venous hypertension caused by venous wall abnormal-
ities and venous valves incompetence [30]. Recent
advantages in understanding of CVD are focused on
role of the leukocytes in the CVD pathogenesis [31].
In CVD patients, intense infiltration of leukocytes
mostly lymphocytes and neutrophiles, was observed.
Lymphocytic changes may suggest implication of
immunological memory in the CVD pathogenesis.
Chronic elevation of the venous pressure may cause
leukocytes and endothelial cells activation [32]. The
extravasation process of leukocytes is divided into
rolling, activation, adhesion and transendothelial
migration [33]. The extravation process of leukocytes
is complicated and involves interactions between
endothelial cells and leukocytes. During rolling leuko-
cytes attach loosely to endothelial cells by L-selectin
and E-selectin [34]. Leukocytes during the rolling
process may meet various chemoattractants, (inter-
leukin 8 (IL-8), complement split products,
macrophage inflammatory protein (MP-1β) and N-
formyl peptides), which biding with leukocytes sur-
face receptors cause their activation [35]. The shed-
ding of adhesion molecules from leukocytes surface
occur as the result of the activating signal. Level of
soluble L-selectin was higher in CVD patients [36]. The
activating signal induces also a conformational changes
in the integrin molecules which results in increment of
their affinity for Ig-superfamily adhesion molecules.
The interaction of integrins and Ig-superfamily adhe-
sion molecules causes firm adhesion of leukocytes to
the endothelial cells and their migration through the
endothelium [37]. Activated leukocytes migrate into
venous wall and venous valve [38]. Leukocytes during
the inflammatory process generate numerous sub-
stances (e.g.: proteolytic enzymes, free radicals and
cytokines), which are responsible for the changes of the
venous wall and venous valve, which lead to venous
wall destruction and valvular incompetence [39]. 
The aim of the study was to investigate and to doc-
ument the memory T cells homeostasis (central, effec-
tor and naive memory T cells) in CVD patients versus
hospitalized abdominal hernia patients. We also evalu-
ated their correlations.
Materials and methods
Patient samples. Group A: 9 patients, 7 women and 2 men aged
32-65, were included in the study. All patients were hospitalized
for surgical removal, by crio-stripping, of varicose veins of the
lower extremities due to chronic venous disorder (CVD). CVD
severity was evaluated using the CEAP (clinical, etiologic,
anatomic, pathophysiologic) classification. Two 10-ml EDTA
blood samples were obtained from all patients prior to the surgery. 
The first blood sample was obtained from a superficial forearm
vein unaffected by CVD. The second blood sample was taken from
a superficial lower limb vessel affected by CVD. Prior to obtaining
blood from a lower limb venous vessel, each patient remained in
an upright position for 20 minutes to provoke a venous stasis in the
pathological superficial venous vessels.  
Group B. 4 patients, 2 women and 2 men aged 19-35, hospitalized
due to abdominal-wall hernia and scheduled for celotomy, were
qualified for the study. None of the control group members dis-
played CVD signs. Blood samples were obtained from a superfi-
cial forearm vein unaffected by CVD directly before surgery.
Isolation of lymphocytes. Mononuclear cells were isolated from
peripheral blood (PBMC). They were isolated by mechanical
Ficoll gradient centrifugation. 
Flow cytometry analysis. Fresh mononuclear cells were directly
stained with anti-human CD4 APC Ab (APC labeled, clone Mouse
IgG1κ, BD Pharmingen), anti-human CD8β PE Ab (PE labeled,
clone 2ST8.5H7, Beckman), anti-human CD28 FITC Ab (FITC
labeled, clone CD28.2, BD Pharmingen), anti-human CD95 Ab (
PE-Cy5 labeled, clone DX2, BD Pharmingen). 
Briefly, 1x106 lymphocytes isolated by Ficoll were incubated
with previously described Abs for 30 minutes at room temperature.
After washing the cells twice in Dulbecco's phosphate buffered
saline supplemented with 2% FCS and fixation in 1%
paraformaldehyde, samples were analyzed by flow cytometry
using The BD FACSCaliburTM system.
For the analysis the memory T cell population was identified
on forward and side scatter for the lymphocyte population and on
CD4 and CD8 expression. TCM were identified as CD28+/CD95+,
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TEM as CD28-/CD95+ and TN as CD28+/CD95-. The date are pre-
sented as percentages of total CD4 and CD8 or as percentages of
TN, TCM and TEM memory cells.
Statistical analysis. The normality of data was evaluated by the
Kolgomorow-Smirnow test and non-normal distribution was
observed in analyzed groups. Statistical analysis was performed
using of the nonparametric U-Mann-Whitney test. Correlations
were assessed using the Spearman correlation method. Values of
p<0.05 were considered as statistically significant. In calculations
Statistica 8.0 software was used.
Results 
After gating on lymphocyte region lymphocytes were
identified as CD4+ T cells and CD8+ T cells and meas-
ured. In the next step TN, TCM and TEM were charac-
terized by the expression of CD28 and CD95 and were
measured.
The quantitative evaluation of total CD4+ and
CD8+ T cells and their particular subsets of memory T
cells: TN, TCM and TEM in peripheral blood in group A
shows that the level of total CD4+ was higher than
total CD8+ in peripheral blood. Among memory T
cells subsets, the level of TCM was the highest and the
level of TEM was the lowest (Fig. 1a). The level of total
CD4+ and CD8+ T cells and their particular subsets of
memory T cells: TN, TEM and TCM was also measured
in blood from varicose veins in group A. The level of
total CD4+ was higher than total CD8+. High levels of
TCM were observed. The level of TN CD8+ was higher
than TEM CD8+, whereas the level of TN CD4+ was
lower than TEM CD4+ (Fig. 1b). Measurements of total
CD4+ and CD8+ T cells and their particular subsets of
memory T cells: TN, TCM and TEM in peripheral blood
in group B also show the higher level of total CD4+
than total CD8+ and that among memory T cells sub-
sets the level of TCM was the highest and of TEM was
the lowest (Fig. 1c).
In this study we also show the comparison between
of total CD4+ and CD8+ and particular subsets of
memory T cells: TN, TCM and TEM in peripheral blood,
among group A and group B. No statistically signifi-
cant differences were found between group A and
group B in terms of total CD4+ and CD8+ T cells and
particular subsets of memory T cells: TN, TCM and TEM
(Fig. 2).
Moreover, we demonstrate correlations in group A
between peripheral blood and blood from varicose
veins in terms of total CD4+ and CD8+ T cells and
particular subsets of memory T cells: TN, TCM and TEM
(Fig. 3). There were almost full correlations of total
CD4+ T cells (r=0.91; p<0.05), total CD8+ T cells
(r=0.96; p<0.05) and TCM CD8+ cells (r=0.95;
p<0.05). Furthermore, there were very high correla-
tions of TCM CD4+ cells (r=0.76; p<0.05), TEM CD4+
cells (r=0.83; p<0.05) and TEM CD8+ cells (r=0.71;
p<0.05). Whereas in TN CD4+ cells (r=0.68; p<0.05)
and TN CD8+ cells (r=0.63; p<0.05) were high corre-
lations. All correlations were statistically significant
besides correlation of TN CD8+ cells. 
Discussion 
Chronic venous disease is very significant problem
among Western population [40,41]. Chronic venous
disease is one of the most common disease, but precise
mechanisms of its pathophysiology remains not well
known [42]. The role of the valvular incompetence and
venous wall abnormalities in the pathophysiology is
well understood. Less is known about the reasons
which lead to the development of these changes [43]. 
Recent studies indicate that always there is present
an inflammatory process during the development of
CVD [44]. In this study using identification of total
CD4+ and CD8+ and particular subsets of memory T
473
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(3): 473 (471-477) 
10.2478/v10042-009-0081-4
Fig. 1. The quantitative evaluation of total CD4+ and CD8+ and
particular subsets of memory T cells: TN, TCM and TEM in group A
and group B.
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Fig. 2. The comparison between total CD4+ and CD8+ and particular subsets of memory T cells: TN, TCM and TEM in peripheral blood,
among group A and group B. 
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Fig. 3. Correlations in group A between peripheral blood and blood from varicose veins in terms of total CD4+ and CD8+ and particular
subsets of memory T cells: TN, TEM and TCM.
cells: TN, TCM and TEM, based on the expression of
CD4, CD8, CD28 and CD95, we show the memory T
cells homeostasis in CVD patients versus hospitalized
abdominal hernia patients.
We have demonstrate that no statistically signifi-
cant differences were between group A and group B in
terms of total CD4+ and CD8+ T cells and particular
subsets of memory T cells: TN, TCM and TEM in periph-
eral blood. While, there were statistically significant
difference between peripheral blood and blood
obtained from varicose veins in terms of previously
described T cells subsets. These results are important
implication about the presence of local inflammatory
conditions.
Results presented in this study show enhanced val-
ues of T cells subpopulations in blood from varicose
veins which can be regarded as lymphocytic changes.
Measurements of particular subsets of memory T cells:
TN, TCM and TEM in blood from varicose veins show
that the level of TCM the highest and the level of TEM
was the lowest. These findings lead us to speculate that
immunological memory T cells may be involved in the
CVD pathogenesis. 
Moreover, the result of the increased level of
lymphocytes in blood obtained from varicose veins
is related to studies focused on intense inflammatory
cells infiltration (mainly lymphocytes) in the venous
valves and venous wall [45]. Leukocytes undergo
activation during chronic elevation of the blood
pressure in veins [46]. Activated cells migrate into
valvular and venous wall and may be responsible for
the changes of the venous wall and venous valve.
Several studies show enhanced infiltration of lym-
phocytes, monocytes, macrophages and neutrophils
into venous wall [32]. Inflammatory cells may
release proteolityc enzymes, free radicals and
cytokines responsible for the destruction of tissue
[47,48]. 
Particular understanding of the inflammatory
process in the development of chronic venous disease
may be significant for treatment of that disease or even
for its prevention. 
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